about
Interaction of tumor cells with the microenvironmentThe CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsMesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineCD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissuesTargeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promisesParallel Aspects of the Microenvironment in Cancer and Autoimmune DiseaseTumor-Associated Macrophages and Neutrophils in Tumor MicroenvironmentLactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic RelevanceRegulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancerPrognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon CancerAdjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunityScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyThe Many Alternative Faces of Macrophage ActivationComplement and macrophage crosstalk during process of angiogenesis in tumor progressionMyeloid suppressor cells and immune modulation in lung cancerWounds that will not heal: pervasive cellular reprogramming in cancerHIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyThe role of neutrophils in the development of liver diseasesTumor immunotherapy: lessons from autoimmunityProstate cancer and parasitism of the bone hematopoietic stem cell nicheMechanisms of age-related macular degenerationImmune modulation of the tumor microenvironment for enhancing cancer immunotherapyMechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissuesExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesThe therapeutic value of targeting inflammation in gastrointestinal cancersPhysical and mechanical regulation of macrophage phenotype and functionOptimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccinesSourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applicationsSpatial and functional heterogeneities shape collective behavior of tumor-immune networksMicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potentialAnti-tumor immunity: myeloid leukocytes control the immune landscapeMannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibodyContext-Specific and Immune Cell-Dependent Antitumor Activities of α1-AntitrypsinElevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin TumorsCancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.Immunological parameters as a new lead in the diagnosis of ovarian cancer.Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised miceProangiogenic scaffolds as functional templates for cardiac tissue engineering.CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network.
P2860
Q21245506-3DA61E04-1AED-4318-81F3-DC93B657A18CQ24631515-E689910F-59AC-4955-84D9-9F979B71BC06Q24632756-8BB97182-1B9E-4AF8-9736-7A063F500C32Q24633702-8071A169-5A89-4C55-8255-D1FD6A73DBD5Q26747140-4396D764-CC7C-455E-A8AF-EF88240BA717Q26753174-6FCB6AE0-80F6-4CCF-BD57-E19C6D3D1756Q26766429-07D14D21-379E-4E1B-938A-DAB880672984Q26766711-300EE316-E098-4DC4-B233-3107A0351F5EQ26773786-BB3D73C0-DE71-4794-A58A-99B96456D145Q26777108-894A2CC7-D447-4460-9DBB-8D0AE5AFF9F3Q26782131-12501606-6C37-4D29-AC62-88AA9E5AB9DFQ26799114-CBD80D69-0759-4BB8-85B0-25B4214E1A48Q26800142-21DE1AA7-9FDB-4B09-8C16-09D00A554E80Q26801339-EAFCB27B-98E7-4AFB-8984-999EBE4B41FFQ26823251-8501F1DC-A745-405C-9BB6-8718056C886FQ26828560-ACC1D1F6-6556-4F8D-8F73-B795F2109A0BQ26859071-7BE94D4A-BDEF-43F5-84EB-2D6D9068B823Q26864040-E53BBED2-FE79-4796-AF1B-1132CE0A21EEQ26866179-8E6385C3-A4F7-4F1F-A658-DE8B67F277DEQ26996231-DAF8FCCC-DC2A-4F6B-99E6-279C264AE3F5Q27000182-A1EB9EEE-877F-43C3-AA44-4C89194A9157Q27002646-0B0BE743-1D6E-429A-84EC-BDB5EBA511ECQ27003907-FC16EDE2-4885-41D6-95C1-C77D22AD664EQ27021694-4340272E-8E7F-4713-AB31-4666F47ECD69Q27024203-D4FD3980-10A2-4EB1-BCFD-3262423328BEQ27024278-218A0CA5-A292-431E-934B-CC4889C17765Q27030560-7D4060D5-F4F2-4B8B-B04A-BFE94BD945F4Q27318423-441E2A3A-1A99-4740-AC66-D575CB219839Q27319519-0DFBC260-FB5D-46C0-A280-252ABD5D0DD9Q28081081-16FD703C-DB7A-4E5F-AAD4-9E4C70218DE9Q28390573-8E73B5D4-6CB1-4AB8-AA63-3AAE161BD480Q28478285-C78B4FA9-0D69-4A29-AA27-7E545D694C91Q28817846-C21F5F1F-F5A7-413D-8C49-C2901119D599Q28829519-56B25165-2D8B-485C-8411-8511531B01BEQ30358706-93D529D8-4D07-4BA8-B799-BCADBE1C6E09Q30414037-1F8A67B8-880B-40D5-BF48-B263A61F4EE3Q30426606-902CCC17-FAAC-4A96-9EA4-D2411ACAAF5BQ30428028-DFF76C8D-FF4D-48B2-BDDD-6DCD2912A8A7Q30496361-D2F2DF80-2CCF-4424-8AF4-36F3BCA92D4AQ30533257-6A2A4407-EB46-4D70-9F21-34C1AF79AD3A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophage polarization in tumour progression.
@en
Macrophage polarization in tumour progression.
@nl
type
label
Macrophage polarization in tumour progression.
@en
Macrophage polarization in tumour progression.
@nl
prefLabel
Macrophage polarization in tumour progression.
@en
Macrophage polarization in tumour progression.
@nl
P2093
P50
P1476
Macrophage polarization in tumour progression.
@en
P2093
Alessandra Mancino
Antonio Sica
Luca Rubino
Maria Grazia Totaro
Monica Rimoldi
Paola Allavena
Subhra Kumar Biswas
P304
P356
10.1016/J.SEMCANCER.2008.03.004
P577
2008-03-26T00:00:00Z